Skip to main content
OpenTrials
Completed

NCT Number: NCT00892372

Relationship Between Body Weight and Glycohemoglobin

Control of body weight (BW) is important to prevent and manage type 2 diabetes. Regardless of the close association, little is understood about the precise relationship between BW and glycemic control, which might be of benefit for patients with type 2 diabetes. The researchers investigated the correlation between changes in BW and glycemic control in patients with type 2 diabetes treated with a diet therapy or pioglitazone.

Completed

Looking for future studies?

Notify Me

Key information

Age range

32 year–76 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Diabetes and Endocrinology, Saitama Medical Center, Saitama Medical University

Kawagoe, Saitama, 350-8550, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • type 2 diabetes under reasonable glycemic control (HbA1c; less than around 7%)
  • type 2 diabetic patients treated with the diet therapy

Exclusion criteria

  • type 2 diabetic patients with edema, severe liver dysfunction, renal dysfunction, moderate to severe anemia or congestive heart failure
  • type 2 diabetic patients treated with insulin therapy

Sponsors and collaborators

Lead sponsor

Saitama Medical University

Other

Registry information

Official study title

Relationship Between Changes in Body Weight and Glycohemoglobin Levels in Patients With Type 2 Diabetes Treated With Diet or Pioglitazone.

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
May 4, 2009
Registry last updated
May 4, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.